Venlafaxine Hydrochloride
Product Images NDC 53217-194

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 53217-194). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (Venlafaxine HCl Er Cadila 1)

A scatter plot chart showing pharmacokinetic fold changes and 90% confidence interval recommendations for venlafaxine hydrochloride with various interacting drugs (ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, lithium). The x-axis represents change relative to the reference value. The chart advises dose adjustment or caution notes for some drug interactions, such as avoiding ethanol, using caution with cimetidine and ketoconazole, and monitoring blood pressure with metoprolol.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (Venlafaxine HCl Er Cadila 2)

A chart displaying the fold change and 90% confidence intervals (CIs) for pharmacokinetic parameters (Cmax and AUC) of various interacting drugs when co-administered with venlafaxine hydrochloride. The horizontal axis represents the change relative to a reference value, with recommendations provided for each interacting drug, including adjustments, cautions, or no dose changes needed.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (Venlafaxine HCl Er Cadila 3)

A scatter plot chart showing fold change and 90% confidence intervals in pharmacokinetic parameters (Cmax and AUC) of venlafaxine hydrochloride across special populations, including hepatic impairment (cirrhosis, mild, moderate), renal impairment (mild/moderate, hemodialysis), CYP2D6 polymorphism, age over 60 years, and gender differences. The chart includes dosage adjustment recommendations based on these changes relative to reference values.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (Venlafaxine HCl Er Cadila 4)

Chemical structure of venlafaxine hydrochloride showing its molecular formula with labeled chemical groups, including a methoxy-substituted aromatic ring, a cyclohexanol group, and a dimethylaminoethyl side chain, accompanied by the HCl notation.*

FDA Label Image

Image Label (Venlafaxine HCl Er Cadila 5)

Label for venlafaxine hydrochloride extended-release capsules, 150 mg strength, in a package of 60 capsules. The label shows product identification as a generic for Effexor XR with NDC 53217-0194-60. It indicates a white and dark orange oblong capsule with imprint ZA-37 150MG. Packaged by Aidarex Pharmaceuticals LLC and manufactured by Cadila Healthcare Limited, India, with additional batch and usage information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.